-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bomedemstat Tosylate in Myelofibrosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bomedemstat Tosylate in Myelofibrosis Drug Details: IMG-7289 is under development for the treatment of acute...
-
Product Insights
NewNeisseria meningitidis Infections – Drugs In Development, 2024
Empower your strategies with our Neisseria meningitidis Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria Meningitidis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord). Symptoms include fever, neck stiffness, joint pain, nausea, confusion and drowsiness. Risk factors include age, smoking, mucosal lesions, overcrowding, climatic conditions such as dry seasons or prolonged drought and dust storms and concomitant respiratory infections. The Neisseria meningitidis Infections drugs...
-
Product Insights
NewLyme Disease – Drugs In Development, 2024
Empower your strategies with our Lyme Disease – Drugs In Development, 2024 report and make more profitable business decisions. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches, and headache. Risk factors include age, gender, and geographic location. Treatment includes antibiotics. The Lyme Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Lyme Disease, complete with...
-
Product Insights
NewPoliomyelitis – Drugs In Development, 2024
Empower your strategies with our Poliomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Polio is a highly infectious disease caused by a virus. It invades the nervous system and can cause total paralysis in a matter of hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis drugs in development market research report provide comprehensive information...
-
Product Insights
NewMiddle East Respiratory Syndrome (MERS) – Drugs In Development, 2024
Empower your strategies with our Middle East Respiratory Syndrome (MERS) – Drugs In Development, 2024 report and make more profitable business decisions. Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting, and diarrhea. Pneumonia is common, and organs damage can occur to the kidneys or other organs. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The...
-
Product Insights
NewPertussis (Whooping Cough) – Drugs In Development, 2024
Empower your strategies with our Pertussis (Whooping Cough) – Drugs In Development, 2024 report and make more profitable business decisions. Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red watery eyes, and dry cough. Treatment includes antibiotics. The Pertussis (Whooping Cough) drugs in development market research report provide comprehensive information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis...
-
Product Insights
NewHand, Foot and Mouth Disease – Drugs In Development, 2024
Empower your strategies with our Hand, Foot and Mouth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – anti-KRAS G12D mTCR PBL in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - anti-KRAS G12D mTCR PBL in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Anti-Kras G12D Mtcr Pbl in Prostate Cancer Drug Details:Gene therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Poliomyelitis [Sabin] (Vero Cell) Vaccine in Poliomyelitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Poliomyelitis [Sabin] (Vero Cell) Vaccine in Poliomyelitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Poliomyelitis [Sabin] (Vero Cell) Vaccine in Poliomyelitis Drug...
-
Product Insights
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Middle East Respiratory Syndrome (MERS) Pipeline Drugs Market Report Overview Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. The MERS pipeline drugs market research report provides comprehensive information on the MERS targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players...